Home
News
News archive
Diamond Information


home > news Only Lyme disease vaccine in development goes to Phase 3 trial

Only Lyme disease vaccine in development goes to Phase 3 trial



Vaccine maker Pfizer says it has begun Phase 3 clinical trial of its vaccine candidate against Lyme disease with French vaccine company Valneva SE.



Click Here to read the entire article...



Find this article in Google